Daniel Clark
Stock Analyst at Leerink Partners
(n/a)
# 4,585
Out of 4,810 analysts
3
Total ratings
n/a
Success rate
-12.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELAN Elanco Animal Health | Initiates: Market Perform | $14 | $8.24 | +69.90% | 1 | Dec 2, 2024 | |
IDXX IDEXX Laboratories | Initiates: Outperform | $500 | $404.02 | +23.76% | 1 | Dec 2, 2024 | |
ZTS Zoetis | Initiates: Outperform | $215 | $149.22 | +44.08% | 1 | Dec 2, 2024 |
Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $8.24
Upside: +69.90%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $404.02
Upside: +23.76%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $149.22
Upside: +44.08%